Naviswiss raises CHF5 million

End of December, Naviswiss announced the successful closing of its financial round E in which it secured CHF 5 million in additional private equity. Round E was led by private investors from Switzerland and is expected to provide funds for further product development and for entering the US and Japanese markets. A few weeks ago Naviswiss established a U.S. Office in Denver, Colorado, after submitting for FDA clearance on Nov 7th, 2019.

Naviswiss provides miniaturized surgical navigation systems to aid orthopedic surgeons in accurately implanting artificial joints. The technology detects leg length changes with accuracy to the millimeter solving one of the most common complications for the patient and risks to the medical community with total hip replacements. An additional risk especially with the popular direct anterior approach (DA), lies in the heavy use of radiation to assess implant placement. Naviswiss can reduce or even eliminate the need for radiation for a DA Hip Replacement.